Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Marin

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Transplantation and Cellular Therapy|June 6, 2022
Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?Rohtesh S Mehta, Rima M Saliba, Eiko Hayase, et al.
Transplantation and Cellular Therapy|May 5, 2022
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideRohtesh S Mehta, Rima M Saliba, Sassine Ghanem, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
Blood|December 16, 2021
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemiaMahmoud R Gaballa, Pinaki Banerjee, Denái R Milton, et al.
Haematologica|June 4, 2026
Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemiaJennifer Miatech, Denái R Milton, Mahmoud R Gaballa, et al.
Haematologica|April 6, 2019
Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trialRohtesh S Mehta, Roland Bassett, Amanda Olson, et al.
Blood|February 2, 2018
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletionBetül Oran, Rima M Saliba, Yudith Carmazzi, et al.
Haematologica|May 30, 2013
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysisFranck E Nicolini, Amr R Ibrahim, Simona Soverini, et al.
Brain Sciences|August 26, 2023
Pharmacological Treatment of Alcohol CravingsMatheus Cheibub David Marin, Maria Olívia Pozzolo Pedro, Giuliana Perrotte, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Transplantation and Cellular Therapy|June 6, 2022
Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?Rohtesh S Mehta, Rima M Saliba, Eiko Hayase, et al.
Transplantation and Cellular Therapy|May 5, 2022
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideRohtesh S Mehta, Rima M Saliba, Sassine Ghanem, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic LeukemiaPiyanuch Kongtim, Uday Popat, Antonio Jimenez, et al.
Blood|December 16, 2021
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemiaMahmoud R Gaballa, Pinaki Banerjee, Denái R Milton, et al.
Haematologica|June 4, 2026
Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemiaJennifer Miatech, Denái R Milton, Mahmoud R Gaballa, et al.
Haematologica|April 6, 2019
Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trialRohtesh S Mehta, Roland Bassett, Amanda Olson, et al.
Blood|February 2, 2018
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletionBetül Oran, Rima M Saliba, Yudith Carmazzi, et al.
Haematologica|May 30, 2013
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysisFranck E Nicolini, Amr R Ibrahim, Simona Soverini, et al.
Brain Sciences|August 26, 2023
Pharmacological Treatment of Alcohol CravingsMatheus Cheibub David Marin, Maria Olívia Pozzolo Pedro, Giuliana Perrotte, et al.
Pageof 18